Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6234-6244

  Tsai, Chih Hsiang ^a   Vivero Escoto, Juan L ^a   Slowing, Igor I ^a   Fang, I Ju ^a   Trewyn, Brian G ^a   Lin, Victor S Y ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Anionic surfactant; Drug delivery system; Intracellular drug delivery; Mesoporous silica nanoparticles; Non cytotoxic nanomaterials; Surfactant assisted drug release

Indexed keywords

AMINOPROPYLTRIMETHOXYSILANE; CARRIER MATERIAL; CELLULAR INTERNALIZATION; CERVICAL CANCER CELLS; CHINESE HAMSTERS; CONTROLLED RELEASE; DELIVERY METHODS; DRUG DELIVERY CARRIER; DRUG DELIVERY SYSTEM; DRUG LOADING; DRUG RELEASE; ENDOSOMES; HYDROPHOBIC DRUG; HYDROPHOBIC ENVIRONMENT; IN-VITRO; INTRACELLULAR DELIVERY; INTRACELLULAR DRUG DELIVERY; LOW WATER; MESOPOROUS; MESOPOROUS SILICA NANOPARTICLES; MESOPOROUS STRUCTURES; MOLAR RATIO; MONOESTERS; NANOVEHICLES; PHYSIOLOGICAL CONDITION; RESVERATROL; STRUCTURE DIRECTING AGENTS; TEMPLATED MESOPOROUS SILICAS; THERAPEUTIC AGENTS; THERAPEUTIC PROPERTIES;

ANIONIC SURFACTANTS; BIOCOMPATIBILITY; BIOPHYSICS; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY; DRUG PRODUCTS; ETHYLENE; ETHYLENE GLYCOL; FLOW CYTOMETRY; HYDROPHOBICITY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; SILICA;

MESOPOROUS MATERIALS;

ANIONIC SURFACTANT; DRUG CARRIER; ETHYLENE GLYCOL; MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; RESVERATROL; SILICON; TETRAMETHOXYSILANE; UNCLASSIFIED DRUG; UNDEC 1 EN 11 YLTETRA(ETHYLENE GLYCOL)PHOSPHATE MONOESTER SURFACTANT;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CHEMICAL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOSOME; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; INTERNALIZATION; MICELLE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SOLUBILITY; SYNTHESIS;

ANIONS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOPARTICLES; POROSITY; SILICON DIOXIDE; STILBENES; SURFACE-ACTIVE AGENTS;

CRICETULUS GRISEUS;

EID: 79959874790     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.077     Document Type: Article

References (64)

1. Shi J., Votruba A.R., Farokhzad O.C., Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010, 10:3223-3230.
2. Shi Y., Porter W., Merdan T., Li L.-C. Recent advances in intravenous delivery of poorly water-soluble compounds. Expert Opin Drug Deliv 2009, 6:1261-1282.
3. Lipinski C. Poor aqueous solubility - an industry wide problem in drug discovery. AmPharm Rev 2002, 5:82-85.
4. Petros R.A., De Simone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010, 9:615-627.
5. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
6. Haag R., Kratz F. Polymer therapeutics: concepts and applications. Angew Chem Int Ed 2006, 45:1198-1215.
7. Boas U., Heegaard P.M.H. Dendrimers in drug research. Chem Soc Rev 2004, 33:43-63.
8. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
9. Anglin E.J., Cheng L., Freeman W.R., Sailor M.J. Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev 2008, 60:1266-1277.
10. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60:1307-1315.
11. Piao Y., Burns A., Kim J., Wiesner U., Hyeon T. Designed fabrication of silica-based nanostructured particle systems for nanomedicine applications. Adv Funct Mater 2008, 18:3745-3758.
12. Sun C., Lee Jerry S.H., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008, 60:1252-1265.
13. Vallet-Regi M. Nanostructured mesoporous silica matrices in nanomedicine. J Int Med 2009, 267:22-43.
14. Liong M., Angelos S., Choi E., Patel K., Stoddart J.F., Zink J.I. Mesostructured multifunctional nanoparticles for imaging and drug delivery. J Mater Chem 2009, 19:6251-6257.
15. Vivero-Escoto J.L., Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles: synthesis and applications. Annu Rev Nano Res 2010, 3:191-231.
16. Hom C., Lu J., Tamanoi F. Silica nanoparticles as a delivery system for nucleic acid-based reagents. J Mater Chem 2009, 19:6308-6316.
17. Manzano M., Vallet-Regi M. New developments in ordered mesoporous materials for drug delivery. J Mater Chem 2010, 20:5593-5604.
18. Vivero-Escoto J.L., Slowing, Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 2010, 6:1952-1967.
19. Coti K.K., Belowich M.E., Liong M., Ambrogio M.W., Lau Y.A., Khatib H.A., et al. Mechanised nanoparticles for drug delivery. Nanoscale 2009, 1:16-39.
20. Slowing, Vivero-Escoto J.L., Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles: structural design and applications. J Mater Chem 2010, 20:7924-7937.
21. Zhao Y., Vivero-Escoto J.L., Slowing, Trewyn B.G., Lin V.S.Y. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. Expert Opin Drug Deliv 2010, 7:1013-1029.
22. He Q., Zhang J., Shi J., Zhu Z., Zhang L., Bu W., et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.
23. Hudson S.P., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials 2008, 29:4045-4055.
24. Lin Y.-S., Haynes C.L. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010, 132:4834-4842.
25. Slowing I., Trewyn B.G., Lin V.S.Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 2006, 128:14792-14793.
26. Slowing, Wu C.-W., Vivero-Escoto J.L., Lin V.S.Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
27. Trewyn B.G., Nieweg J.A., Zhao Y., Lin V.S.Y. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem Eng J 2008, 137:23-29.
28. Vivero-Escoto J.L., Slowing, Lin V.S.Y. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials 2010, 31:1325-1333.
29. Tsai C.-P., Chen C.-Y., Hung Y., Chang F.-H., Mou C.-Y. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 2009, 19:5737-5743.
30. Lebedev O.I., Van Tendeloo G., Collart O., Cool P., Vansant E.F. Structure and microstructure of nanoscale mesoporous silica spheres. Solid State Sci 2004, 6:489-498.
31. Cauda V., Argyo C., Schlossbauer A., Bein T. Controlling the delivery kinetics from colloidal mesoporous silica nanoparticles with pH-sensitive gates. J Mater Chem 2010, 20:4305-4311.
32. Cheng S.-H., Lee C.-H., Chen M.-C., Souris J.S., Tseng F.-G., Yang C.-S., et al. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy. J Mater Chem 2010, 20:6149-6157.
33. Thomas C.R., Ferris D.P., Lee J.-H., Choi E., Cho M.H., Kim E.S., et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc 2010, 132:10623-10625.
34. Wang L.-S., Wu L.-C., Lu S.-Y., Chang L.-L., Teng I.T., Yang C.-M., et al. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding. ACS Nano 2010, 4:4371-4379.
35. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2010, 132:552-557.
36. Giri S., Trewyn B.G., Stellmaker M.P., Lin V.S.Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed 2005, 44:5038-5044.
37. Vivero-Escoto J.L., Slowing, Wu C.-W., Lin V.S.Y. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 2009, 131:3462-3463.
38. Zhao Y., Trewyn B.G., Slowing, Lin V.S.Y. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. J Am Chem Soc 2009, 131:8398-8400.
39. Schlossbauer A., Warncke S., Gramlich P.M.E., Kecht J., Manetto A., Carell T., et al. A programmable DNA-based molecular valve for colloidal mesoporous silica. Angew Chem Int Ed 2010, 49:4734-4737.
40. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007, 46:7548-7558.
41. Lu J., Choi E., Tamanoi F., Zink J.I. Light-activated nanoimpeller-controlled drug release in cancer cells. Small 2008, 4:421-426.
42. Tyner K.M., Schiffman S.R., Giannelis E.P. Nanobiohybrids as delivery vehicles for camptothecin. J Control Release 2004, 95:501-514.
43. Clifford N.W., Iyer K.S., Raston C.L. Encapsulation and controlled release of nutraceuticals using mesoporous silica capsules. J Mater Chem 2008, 18:162-165.
44. Vlachy N., Touraud D., Heilmann J., Kunz W. Determining the cytotoxicity of catanionic surfactant mixtures on HeLa cells. Colloids Surf B 2009, 70:278-280.
45. He Q., Shi J., Chen F., Zhu M., Zhang L. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010, 31:3335-3346.
46. Gao C., Che S. Organically functionalized mesoporous silica by co-structure-directing route. Adv Funct Mater 2010, 20:2750-2768.
47. Yokoi T., Tatsumi T. Synthesis of mesoporous silica materials by using anionic surfactants as template. J Jpn Pet Inst 2007, 50:299-311.
48. Che S., Garcia-Bennett A.E., Yokoi T., Sakamoto K., Kunieda H., Terasaki O., et al. A novel anionic surfactant templating route for synthesizing mesoporous silica with unique structure. Nat Mater 2003, 2:801-805.
49. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5:493-506.
50. Shukla Y., Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci 2011, 1215:1-8.
51. Pale-Grosdemange C., Simon E.S., Prime K.L., Whitesides G.M. Formation of self-assembled monolayers by chemisorption of derivatives of oligo(ethylene glycol) of structure HS(CH2)11(OCH2CH2)mOH on gold. J Am Chem Soc 1991, 113:12-20.
52. Hed J., Hallden G., Johansson S.G., Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 1987, 101:119-125.
53. Bailey J.K., Mecartney M.L. Formation of colloidal silica particles from alkoxides. Colloids Surf 1992, 63:151-161.
54. Van Tendeloo G., Lebedev O.I., Collart O., Cool P., Vansant E.F. Structure of nanoscale mesoporous silica spheres?. J Phys Condens Matter 2003, 15:S3037-S3046.
55. Tan B., Rankin S.E. Interfacial alignment mechanism of forming spherical silica with radially oriented nanopores. J Phys Chem B 2004, 108:20122-20129.
56. Wang J.-G., Xiao Q., Zhou H.-J., Sun P.-C., Ding D.-T., Chen T.-H. Anionic surfactant-templated mesoporous silica (AMS) nano-spheres with radially oriented mesopores. J Colloid Interface Sci 2008, 323:332-337.
57. Gao C., Qiu H., Zeng W., Sakamoto Y., Terasaki O., Sakamoto K., et al. Formation mechanism of anionic surfactant-templated mesoporous silica. Chem Mater 2006, 18:3904-3914.
58. Chung T.-H., Wu S.-H., Yao M., Lu C.-W., Lin Y.-S., Hung Y., et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007, 28:2959-2966.
59. Zhao Y., Sun X., Zhang G., Trewyn B.G., Slowing, Lin V.S.Y. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 2011, 5:1366-1375.
60. Yokoi T.Y., Yamada T., Kubota Y., Tatsumi T. Amino-functionalized mesoporous silica synthesized by an anionic surfactant templating route. J Mater Chem 2006, 16:1125-1135.
61. Walle T., Hsieh F., DeLegge M.H., Oatis J.E., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004, 32:1377-1382.
62. Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci 2011, 1215:9-15.
63. Delmas D., Aires V., Limagne E., Dutartre P., Mazue F., Ghiringhelli F., et al. Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci 2011, 1215:48-59.
64. Sainz R.M., Mayo J.C., Tan D.-X., Lopez-Burillo S., Natarajan M., Reiter R.J. Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem Biophys Res Commun 2003, 302:625-634.